Home » Posts tagged with » Pipeline Therapeutics
PIPE-505 : Pipeline Therapeutics initiates phase 1/2a SNHL trial
Pipeline Therapeutics has initiated a phase 1/2a trial of PIPE-505, which is a small molecule gamma secretase inhibitor (GSI), in patients who have sensorineural hearing loss (SNHL) associated with hearing speech in noisy environments. The phase 1/2a trial is anticipated to take in 24 adult patients, and will be carried out as a randomized, double-blind, […]
Business News Today
- Kia Motors unveils Kia Sonet, new compact SUV made in India
- MiddleGround Capital acquires majority stake in Dura Automotive Systems
- Third Point Re to acquire rival reinsurer Sirius Group for $788m
- Intercontinental Exchange to acquire mortgage software provider Ellie Mae
- Noble Foods Nutrition acquires co-packing activities of Betty Lou’s
- Logo Brands acquires Boelter Brands drinkware and Topperscot lines
- Alliant Networks acquires 4G Underground Construction
- Vieroots Wellness Solutions secures investment from actor Suniel Shetty
- Medline to acquire SensiCare, Aloe Vesta skin care products from ConvaTec
- Arthur J. Gallagher acquires Canada-based Insight Insurance & Risk Management
